Long Term Management of Arrhythmias Flashcards
Long-term Management of Symptomatic Nonsustained VT Initial Therapy
β-Blockers may be considered for a therapeutic trial in symptomatic patients
Non-dihydropyridine CCBs may be considered as an alternative
Long-term Management of Symptomatic Nonsustained VT Secondary Therapy
AAD therapy (amiodarone, flecainide, mexiletine, propafenone, sotalol) may be considered to
improve symptoms associated with arrhythmias in patients receiving adequate doses of a β-blocker
or CCB
β-Blockers use with ICD
Considered mainstay therapy
Effective in suppressing ventricular ectopic beats and in reducing SCD in a spectrum of cardiac
disorders in patients with and without HF (nonsustained VT)
Amiodarone use with ICD
Can be used in combination with β-blockers to decrease firing of IC; Increases threshold
Sotalol use with ICD
Can suppress VT and be used to decrease frequency of ICD firing; decreases threshold